This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Stay updated with the latest weekly cash back credit card deals to maximize your savings. Don't miss these offers!
23,042 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
As market rates swing and volatility persists, a 4.75% yield from an active covered-call ETF is reshaping retirement ...
The billionaire bill gates' foundation recently remade its public equity lineup, selling its Microsoft stake and conc...
MongoDB is set to release its Q1 results after the bell, with investors looking for Atlas expansion, solid cash flow,...
June brings three key events that can move Disney stock. This guide explains the dates Disney stock investors should ...
When a CEO sells 38,000 Innodata shares, investors often wonder if the move signals trouble or simply a personal liqu...
Energy prices and geopolitical risk pushed major indices lower, snapping a string of gains. This guide explains why t...
A $650,000 portfolio could potentially cover a yearly luxury trip if the income approach is right, balancing high-yie...
The nuclear energy story 2026 is taking shape as decarbonization and power-hungry data demand push expansion. This gu...
Feeling uncertain about when to claim Social Security? This guide breaks down the trade-offs of early, at FRA, or lat...
Tesla sits at a fair-value crossroads in 2026, with capex and AI initiatives guiding a modest upside. Here’s how inve...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...